Literature DB >> 19060228

Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury.

Gilman B Allen1, Mary E Cloutier, Yuna C Larrabee, Konstantin Tetenev, Stephen T Smiley, Jason H T Bates.   

Abstract

Fibrin impairs surfactant function in vitro, and inhibition of fibrinolysis by plasminogen activator inhibitor (PAI-1) is thought to promote fibrin accumulation in acute lung injury (ALI). This has led to speculation that impaired PAI-1 and fibrin accumulation should protect lung function in ALI. We tested this hypothesis by investigating ALI severity in fibrinogen-deficient (Fgn-/-) and PAI-1-deficient (PAI-1-/-) mice. PAI-1-/-, C57BL/6, Fgn-/-, and Fgn+/- females were anesthetized and allowed to aspirate 4 microl/g of hydrochloric acid (pH 1.0) and then reanesthetized and connected to a ventilator 48 h later. Naive C57BL/6 and Fgn+/- females served as controls. Following deep inflation (DI), forced oscillations were delivered periodically over 8 min to measure changes in elastance (H) as a surrogate of lung derecruitment, at positive end-expiratory pressures (PEEP) of 6, 3, and 1 cmH(2)O. Increases in H following DI in acid-injured mice were greater than naive strain-matched controls. Increases in H were no different between injured PAI-1-/- and C57BL/6, or between injured Fgn-/- and +/- mice, at any PEEP. Pressure-volume curves were no different between injured groups. Total lung fibrin was lower in injured PAI-1-/- and Fgn-/- mice relative to injured C57BL/6 and Fgn+/- mice, respectively, but indices of permeability were no different between strains. Unexpectedly, neither fibrin nor PAI-1 deficiency protects lung mechanical function in mice with acid-induced ALI. We speculate that in vivo lung function may be more closely tied to permeability and alveolar protein in general, rather than being linked specifically to fibrin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060228      PMCID: PMC2660214          DOI: 10.1152/ajplung.90475.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  64 in total

Review 1.  Anticoagulant therapy in acute lung injury.

Authors:  Pierre-François Laterre; Xavier Wittebole; Jean-François Dhainaut
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 2.  Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.

Authors:  Steven Idell
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

4.  Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model.

Authors:  Osamu Tasaki; David W Mozingo; Michael A Dubick; Cleon W Goodwin; Loudon D Yantis; Basil A Pruitt
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

5.  Variable protection of beta 3-integrin--deficient mice from thrombosis initiated by different mechanisms.

Authors:  S S Smyth; E D Reis; H Väänänen; W Zhang; B S Coller
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

6.  Effects of simultaneous exposure of surfactant to serum proteins and free radicals.

Authors:  Yolanda Marzan; Rene Mora; Aaron Butler; Matthew Butler; Edward P Ingenito
Journal:  Exp Lung Res       Date:  2002-03       Impact factor: 2.459

7.  The response to recruitment worsens with progression of lung injury and fibrin accumulation in a mouse model of acid aspiration.

Authors:  Gilman B Allen; Timothy Leclair; Mary Cloutier; John Thompson-Figueroa; Jason H T Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-09       Impact factor: 5.464

8.  Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.

Authors:  Priya Prabhakaran; Lorraine B Ware; Kimberly E White; Michael T Cross; Michael A Matthay; Mitchell A Olman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-02       Impact factor: 5.464

Review 9.  Coagulation and inflammation in acute lung injury.

Authors:  Karen E Welty-Wolf; Martha S Carraway; Thomas L Ortel; Claude A Piantadosi
Journal:  Thromb Haemost       Date:  2002-07       Impact factor: 5.249

10.  Fibrin-mediated protection against infection-stimulated immunopathology.

Authors:  Lawrence L Johnson; Kiera N Berggren; Frank M Szaba; Wangxue Chen; Stephen T Smiley
Journal:  J Exp Med       Date:  2003-03-10       Impact factor: 14.307

View more
  14 in total

1.  Computational Models of Ventilator Induced Lung Injury and Surfactant Dysfunction.

Authors:  Jason H T Bates; Bradford J Smith; Gilman B Allen
Journal:  Drug Discov Today Dis Models       Date:  2014-04-29

2.  Platelets induce endothelial tissue factor expression in a mouse model of acid-induced lung injury.

Authors:  Memet T Emin; Li Sun; Alice Huertas; Shonit Das; Jahar Bhattacharya; Sunita Bhattacharya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-04-13       Impact factor: 5.464

Review 3.  Coagulation and autoimmunity in scleroderma interstitial lung disease.

Authors:  Anna Ludwicka-Bradley; Richard M Silver; Galina S Bogatkevich
Journal:  Semin Arthritis Rheum       Date:  2010-12-17       Impact factor: 5.532

4.  Wood bark smoke induces lung and pleural plasminogen activator inhibitor 1 and stabilizes its mRNA in porcine lung cells.

Authors:  Krishna K Midde; Andriy I Batchinsky; Leopoldo C Cancio; Sreerama Shetty; Andrey A Komissarov; Galina Florova; Kerfoot P Walker; Kathy Koenig; Zissis C Chroneos; Tim Allen; Kevin Chung; Michael Dubick; Steven Idell
Journal:  Shock       Date:  2011-08       Impact factor: 3.454

Review 5.  Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.

Authors:  Nasser Chegini
Journal:  Semin Reprod Med       Date:  2010-04-22       Impact factor: 1.303

6.  Activation of NFkB and coagulation in lung injury by hyperoxia and excessive mechanical ventilation: one more reason "low and slow" is the way to go?

Authors:  Jeffrey R Jacobson; Konstantin G Birukov
Journal:  Transl Res       Date:  2009-08-25       Impact factor: 7.012

7.  The Temporal Evolution of Airways Hyperresponsiveness and Inflammation.

Authors:  Erik Riesenfeld; Gilman B Allen; Jason Ht Bates; Matthew E Poynter; Min Wu; Steven Aimiand; Lennart Ka Lundblad
Journal:  J Allergy Ther       Date:  2012-01-25

8.  Acid aspiration-induced airways hyperresponsiveness in mice.

Authors:  Gilman B Allen; Timothy R Leclair; Jessica von Reyn; Yuna C Larrabee; Mary E Cloutier; Charles G Irvin; Jason H T Bates
Journal:  J Appl Physiol (1985)       Date:  2009-10-01

9.  Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins.

Authors:  Mustafa Al-Saiedy; Lasantha Gunasekara; Francis Green; Ryan Pratt; Andrea Chiu; Ailian Yang; John Dennis; Cora Pieron; Candice Bjornson; Brent Winston; Matthias Amrein
Journal:  Mil Med       Date:  2018-03-01       Impact factor: 1.437

10.  Variable Ventilation as a Diagnostic Tool for the Injured Lung.

Authors:  Bradford J Smith; Jason H T Bates
Journal:  IEEE Trans Biomed Eng       Date:  2014-04-07       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.